Yan Ding
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 8
-
- RNA modifications and cancer 11
- Circular RNAs in diseases 7
- Epigenetics and DNA Methylation 7
- Ubiquitin and proteasome pathways 6
- Pluripotent Stem Cells Research 6
- Co-authors
- Xin Chen (10 shared papers)Jinbao Liu (10 shared papers)Daolin Tang (9 shared papers)Øystein Fodstad (3 shared papers)Yuhua Zhao (3 shared papers)Ming Tan (3 shared papers)Ming Zhou (2 shared papers)Kangping Cui (9 shared papers)
- Journals
- Journal of Hazardous Materials (4 papers)Oncotarget (3 papers)Cell Death Discovery (3 papers)Oncology Reports (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Yan Ding
147 papers receiving 3.8k citations
Yan Ding's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 934
- Biochemistry 245
- Molecular Biology 1.6k
- Water Science and Technology 239
- Pulmonary and Respiratory Medicine 478
Countries citing papers authored by Yan Ding
This map shows the geographic impact of Yan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ding more than expected).
Fields of papers citing papers by Yan Ding
This network shows the impact of papers produced by Yan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ding. The network helps show where Yan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Copper-dependent autophagic degradation of GPX4 drives ferroptosis Hit paper breakdown → | 2023 | 511 |
| 2 | 2010 | 367 | |
| 3 | 2009 | 224 | |
| 4 | 2021 | 189 | |
| 5 | H3K18 lactylation of senescent microglia potentiates brain aging and Alzheimer's disease through the NFκB signaling pathway Hit paper breakdown → | 2023 | 181 |
| 6 | 2013 | 120 | |
| 7 | 2012 | 94 | |
| 8 | 2019 | 92 | |
| 9 | 2020 | 90 | |
| 10 | 2023 | 65 | |
| 11 | 2015 | 61 | |
| 12 | 2012 | 61 | |
| 13 | 2005 | 57 | |
| 14 | 2023 | 54 | |
| 15 | 2013 | 51 | |
| 16 | 2022 | 49 | |
| 17 | 2021 | 48 | |
| 18 | 2014 | 44 | |
| 19 | 2019 | 42 | |
| 20 | 2024 | 42 |
About Yan Ding
Yan Ding is a scholar working on Cancer Research, Molecular Biology, Immunology, Epidemiology and Oncology, having authored 161 papers that have together received 3.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers), Autophagy in Disease and Therapy (9 papers), MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers), Epigenetics and DNA Methylation (7 papers), Ubiquitin and proteasome pathways (6 papers) and Pluripotent Stem Cells Research (6 papers). The work is most often cited by research in Cancer Research (934 citations), Biochemistry (245 citations), Molecular Biology (1.6k citations), Water Science and Technology (239 citations) and Pulmonary and Respiratory Medicine (478 citations). Yan Ding has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Xin Chen, Jinbao Liu, Daolin Tang, Øystein Fodstad, Yuhua Zhao, Ming Tan, Ming Zhou, Kangping Cui, Yihan Chen and Xiaofen Li. Their work appears in journals such as Journal of Hazardous Materials, Oncotarget, Cell Death Discovery, Oncology Reports and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.